MDA-MB-231 is a triple-negative breast cancer (TNBC), defined as a tumor negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [17, 18]. This evidence concerns the gene PGR and neoplasm.